Viral Hepatitis
Copyright ©The Author(s) 2004.
World J Gastroenterol. May 15, 2004; 10(10): 1436-1439
Published online May 15, 2004. doi: 10.3748/wjg.v10.i10.1436
Table 1 ALT, AST, TB and HBVDNA levels before and after treatment (mean ± SD)
nALT (U/L)AST (U/L)TB (μmol/L)HBVDNA (copy/mL)
Normal1027.80 ± 8.6519.07 ± 8.5012.55 ± 5.520
TreatmentPre-T40213.66 ± 10.30134.66 ± 9.8241.03 ± 4.36(1.52 ± 0.72) × 108.25
Post-T4037.01 ± 9.75b29.07 ± 8.97b20.55 ± 5.52b(4.25 ± 1.90) × 106.02 a
ControlPre-T25195.70 ± 11.11125.12 ± 9.2140.87 ± 6.78(1.32 ± 0.89) × 108.12
Post-T2536.01 ± 9.75b69.88 ± 8.97b30.55 ± 5.52b(6.95 ± 2.39) × 107.82
Table 2 T lymphocyte subsets before and after treatment (mean ± SD)
nCD3 (%)CD4 (%)CD8 (%)CD4/CD8
Normal1067.80 ± 8.6539.07 ± 8.5030.55 ± 5.521.62 ± 0.46
TreatmentPre-T4065.97 ± 8.4534.76 ± 4.82b34.08 ± 4.36b1.04 ± 0.32
Post-T4067.01 ± 9.7537.39 ± 8.97a32.35 ± 5.52a1.20 ± 0.30a
ControlPre-T2565.70 ± 9.1135.02 ± 5.21b34.87 ± 6.78b1.02 ± 0.29
Post-T2566.01 ± 9.7535.88 ± 8.9734.15 ± 5.521.09 ± 0.39
Table 3 T lymphocyte subsets of responders and non-respond-ers in treatment group before and after treatment (mean ± SD)
nCD3 (%)CD4 (%)CD8 (%)
RespondersPre-T666.62 ± 8.8635.10 ± 4.76b34.02 ± 4.86b
Post-T666.80 ± 9.1138.85 ± 8.85a30.15 ± 5.82a
Non-respondersPre-T3465.86 ± 9.0834.62 ± 6.30b34.17 ± 6.56b
Post-T3466.09 ± 9.3535.72 ± 8.7033.85 ± 5.52
Normal1067.80 ± 8.6539.07 ± 8.5030.55 ± 5.52